1. Home
  2. PUBM vs MLTX Comparison

PUBM vs MLTX Comparison

Compare PUBM & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PubMatic Inc.

PUBM

PubMatic Inc.

N/A

Current Price

$16.03

Market Cap

847.2M

Sector

Technology

ML Signal

N/A

Logo MoonLake Immunotherapeutics

MLTX

MoonLake Immunotherapeutics

N/A

Current Price

$11.91

Market Cap

863.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PUBM
MLTX
Founded
2006
2021
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
847.2M
863.0M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
PUBM
MLTX
Price
$16.03
$11.91
Analyst Decision
Buy
Buy
Analyst Count
13
15
Target Price
$21.00
★ $28.54
AVG Volume (30 Days)
495.5K
★ 1.9M
Earning Date
11-09-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $282,926,000.00
N/A
Revenue This Year
$9.05
N/A
Revenue Next Year
$8.32
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$6.15
$9.46
52 Week High
$19.30
$23.29

Technical Indicators

Market Signals
Indicator
PUBM
MLTX
Relative Strength Index (RSI) 36.62 51.73
Support Level $16.02 $11.88
Resistance Level $18.16 $13.51
Average True Range (ATR) 0.79 0.77
MACD -0.19 0.33
Stochastic Oscillator 4.03 63.37

Price Performance

Historical Comparison
PUBM
MLTX

About PUBM PubMatic Inc.

PubMatic Inc is is an independent, artificial intelligence-powered advertising technology company that delivers digital advertising performance. Its integrated technology platform connects buyers, publishers, data providers, and commerce media networks on a single, unified platform, to deliver advertising performance, control, transparency and efficiency. Its platform empowers the world's digital content creators (publishers) to maximize monetization of their advertising inventory and audiences and provides control and transparency to buyers, which includes advertisers, agencies, agency trading desks, and demand side platforms (DSPs) (referred as buyers). Geographically, the company generates the majority of its revenue from the United States, followed by EMEA, APAC, and Rest of the World.

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.

Share on Social Networks: